GB704516A - A blood anticoagulating agent and process for the manufacture thereof - Google Patents

A blood anticoagulating agent and process for the manufacture thereof

Info

Publication number
GB704516A
GB704516A GB17341/52A GB1734152A GB704516A GB 704516 A GB704516 A GB 704516A GB 17341/52 A GB17341/52 A GB 17341/52A GB 1734152 A GB1734152 A GB 1734152A GB 704516 A GB704516 A GB 704516A
Authority
GB
United Kingdom
Prior art keywords
acid
chondroitin
product
sulphuric acid
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB17341/52A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Products Ltd
Original Assignee
Roche Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Products Ltd filed Critical Roche Products Ltd
Publication of GB704516A publication Critical patent/GB704516A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises a blood-anticoagulating agent comprising a polysulphuric acid ester of a hydrolytically degraded chondroitin-sulphuric acid, said ester having a sulphur content of between 11 and 16 per cent. and an intrinsic viscosity of from 0.05 and 0.10, and alkali salts of the same. They are prepared by hydrolyzing chondroitin-sulphuric acid until a product having an intrinsic viscosity of below 0.25 is obtained, and then converting to a polysulphuric acid, e.g. by treatment with chlorosulphonic acid, sulphur trioxide or oleum in the presence of an organic base such as pyridine, quinoline or a -picoline. The hydrolyzed material, before or after sulphation, may be subject to fractional precipitation, e.g. by means of acetone, methanol or ethanol. An example is given in which chondroitin-sulphuric acid is hydrolyzed with hydrochloric acid, esterified with chlorosulphonic acid in the presence of pyridine, and the product purified by precipitating it as the insoluble narcotine salt from which the product is finally recovered by treatment with aqueous sodium carbonate.
GB17341/52A 1951-07-12 1952-07-09 A blood anticoagulating agent and process for the manufacture thereof Expired GB704516A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH704516X 1951-07-12

Publications (1)

Publication Number Publication Date
GB704516A true GB704516A (en) 1954-02-24

Family

ID=4530287

Family Applications (1)

Application Number Title Priority Date Filing Date
GB17341/52A Expired GB704516A (en) 1951-07-12 1952-07-09 A blood anticoagulating agent and process for the manufacture thereof

Country Status (1)

Country Link
GB (1) GB704516A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112500384A (en) * 2020-12-07 2021-03-16 九江学院 Synthetic method of flavonoid sulfate and application thereof under acidic condition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112500384A (en) * 2020-12-07 2021-03-16 九江学院 Synthetic method of flavonoid sulfate and application thereof under acidic condition
CN112500384B (en) * 2020-12-07 2023-10-17 九江学院 Application of flavonoid sulfate in acidic condition

Similar Documents

Publication Publication Date Title
GB704516A (en) A blood anticoagulating agent and process for the manufacture thereof
GB735408A (en) Chlorotoloxy-ethyl sulphates
US1573738A (en) Preparation of organic derivatives of tin
GB452868A (en) Manufacture of salts of cyclic nitrogen bases
US1863676A (en) Amino-hydroxy pyridine and process of preparing the same
GB541528A (en) Improvements in or relating to the hydrolysis of pectin
US1674362A (en) Complex antimony compound
GB746870A (en) Preparation of sulphated chitosan
US1483217A (en) Analgesic compound and process of producing the same
GB580509A (en) Process for the manufacture of pantothenic acid and its salts
GB796737A (en) A process for the production of glycan poly-(sulphuric acid esters)
GB695493A (en) Process for producing alpha-mercapto-carboxylic acids
GB763911A (en) A blood anticoagulating agent and process for the manufacture thereof
GB380083A (en) An improved process for producing complex metal compounds of pyridine carboxylic acids containing one or more sulphhydryl residues
GB715821A (en) Improvements relating to the manufacture of sulphuric esters of dextran
GB579001A (en) Manufacture of new derivatives of 4:4-diamino-diphenylsulphones
GB384558A (en) Improvements in the purification and decolorisation of aromatic hydroxy-carboxylic ac
GB796477A (en) New anticoagulant and a method of preparing same
US1753170A (en) Process for introduction of iodine into pyridine derivatives
GB231800A (en) Manufacture of new cellulose compounds
GB859278A (en) A method of preparing a physiologically active product of amylose
GB666920A (en) An anticoagulating agent and process for the manufacture thereof
GB265777A (en) Improved process for the manufacture of organic auro-mercapto acids and salts thereof
GB177283A (en) Improvements in or relating to the manufacture of derivatives of 3.3 diamino 4.4 dihydroxyarsenobenzene
GB378906A (en) Improvements in or relating to the preparation of titanium compounds